The online version of this article (doi:10.1186/1477-7819-10-119) contains supplementary material, which is available to authorized users.
The authors declare they have no competing interests.
ZW carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JHS carried out cell separation and culture. ZC participated in the design of the study and performed the statistical analysis. HW conceived the study, participated in its design and coordination, and helped to draft the manuscript. JXC is the guarantor of the integrity of the entire study. All authors read and approved the final manuscript.
A key factor underlying the control of the cellular growth, size and proliferation involves the regulation of the total protein synthesis. Most often, the initial stages of mRNA translation are rate limiting, which involves a group of eukaryotic translation initiation factors (EIFs). Research advances focused on the inhibition of their expression and activity hold the key to the initiation and progression of tumor and tumor prognosis.
We performed RNA interference (RNAi) with the lentivirus vector system to silence the EIF3B gene using the colon cancer cell strain SW1116. The negative control included the normal target cells infected with the negative control virus whereas the knockdown cells included the normal target cells transfected with the RNAi target virus. We tested the inhibition resulting from the decreased expression of EIF3B gene on the proliferation rate of SW1116 cells, including the cell cycle, apoptosis and clonability.
Compared with the negative control, the impact of EIF3B gene expression in SW1116 cells on the levels of mRNA and protein in the knockdown group, was significantly inhibited (P <0.01). Furthermore, the cell proliferation rate and clonability were also significantly inhibited (P <0.01). The apoptosis rate increased significantly (P <0.05). A significant decrease in the number of cells in the G1 phase (P <0.01) and significant increases in S (P <0.01) and G2 phases (P <0.05) were observed.
The silencing of EIF3B gene expression inhibits the proliferation of colon cancer cells.
Authors’ original file for figure 112957_2012_1038_MOESM1_ESM.tiff
Authors’ original file for figure 212957_2012_1038_MOESM2_ESM.tiff
Authors’ original file for figure 312957_2012_1038_MOESM3_ESM.tiff
Authors’ original file for figure 412957_2012_1038_MOESM4_ESM.tiff
Authors’ original file for figure 512957_2012_1038_MOESM5_ESM.tiff
Authors’ original file for figure 612957_2012_1038_MOESM6_ESM.tiff
Authors’ original file for figure 712957_2012_1038_MOESM7_ESM.tiff
Authors’ original file for figure 812957_2012_1038_MOESM8_ESM.tiff
Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Shichita M, Yamamoto N, Yamamoto M: Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res. 2000, 20: 2489-2494. PubMed
Elantak L, Wagner S, Herrmannova A, Karaskova M, Rutkai E, Lukavsky PJ, Valasek L: The indispensable N-terminal half of eIF3j/HCR1 cooperates with its structurally conserved binding partner EIF3B/PRT1-RRM and with eIF1A in stringent AUG selection. J Mol Biol. 2010, 396: 1097-1116. 10.1016/j.jmb.2009.12.047. PubMedCentralCrossRefPubMed
Zhou M, Sandercock AM, Fraser CS, Ridlova G, Stephens E, Schenauer MR, Yokoi-Fong T, Barsky D, Leary JA, Hershey JW, Doudna JA, Robinson CV: Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3. Proc Natl Acad Sci USA. 2008, 105: 18139-18144. 10.1073/pnas.0801313105. PubMedCentralCrossRefPubMed
Cappuzzo F, Varella-Garcia M, Rossi E, Gajapathy S, Valente M, Drabkin H, Gemmill R: MYC and EIF3H coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol. 2009, 4: 472-478. 10.1097/JTO.0b013e31819a5767. PubMedCentralCrossRefPubMed
Nupponen NN, Porkka K, Kakkola L, Tanner M, Persson K, Borg A, Isola J, Visakorpi T: Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol. 1999, 154: 1777-1783. 10.1016/S0002-9440(10)65433-8. PubMedCentralCrossRefPubMed
Marchetti A, Buttitta F, Pellegrini S, Bertacca G, Callahan R: Reduced expression of INT-6/eIF3-p48 in human tumors. Int J Oncol. 2001, 18: 175-179. PubMed
- RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II